amylyx.comHealthcareFounded: 2014Funding to Date: $203.25MM
Amylyx is a pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis (ALS), Alzheimer’s disease and other neurodegenerative diseases.
View Enterprise Value for Amylyx.